Therapy News and Research

RSS

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's Health researchers and published today in Cancer Research Communications, a journal of the American Association for Cancer Research.

9 Jan 2024

New study sheds light on the biological properties of new COVID variant Pirola

Despite the end of the pandemic, COVID-19 continues to pose a serious health threat. Most individuals have established robust immune protection and do not develop severe disease but the infection can still lead to marked and sometimes long-lasting disease symptoms.

9 Jan 2024

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a global life sciences and diagnostics innovator.

9 Jan 2024

Children with neuroblastomas may benefit from new drug cocktail

Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumor drugs as well as chemotherapy, a new trial has found.

9 Jan 2024

Marking a vital milestone for Vertex and Charles River

Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease

From Charles River 9 Jan 2024

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives.

From Cellular Origins 9 Jan 2024

Rising malpractice premiums price small clinics out of gender-affirming care for minors

After Iowa lawmakers passed a ban on gender-affirming care for minors in March, managers of an LGBTQ+ health clinic located just across the state line in Moline, Illinois, decided to start offering that care.

9 Jan 2024

Infammasomes provide a therapeutic target against human diseases

The structure of inflammasomes and their role in diseases.

9 Jan 2024

Amino acid nanoparticles show promise for cancer treatment

Amino acids, such as tyrosine and tryptophan, are the fundamental building blocks that make up proteins.

8 Jan 2024

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

Photobiomodulation alleviates Aβ deposition and cognitive decline in mice with Alzheimer’s disease

Alzheimer's disease (AD) is an age-related neurodegenerative disorder. β-amyloid (Aβ) deposition in the brain is a crucial contributor to the pathogenesis of AD, mitigating excessive cerebral Aβ burden has been considered as a possible therapeutic strategy for AD.

8 Jan 2024

New peptide library paves the way for targeting elusive cancer factor MYC

Researchers developed a second-generation NTB bicyclic peptide library, identifying NT-B2R, a peptide that effectively targets MYC, a key factor in most human cancers, demonstrating its potential in inhibiting MYC transcription activities and cancer cell proliferation.

8 Jan 2024

URI robot aims to accelerate motor skill restoration for stroke patients

Every year, about 800,000 new stroke cases are reported in the United States, often causing patients problems with both neurological and physical motor control. Disruptions in the mobility of the arms and hands, in particular, can have devastating impacts on stroke patients' quality of life.

8 Jan 2024

Unraveling the brain-fat pathway that dictates aging in mice

In recent years, research has begun to reveal that the lines of communication between the body's organs are key regulators of aging.

8 Jan 2024

Three cytokine pairs found to be responsible for the body's damaging response to sepsis

Sepsis - when an infection causes the immune system to improperly target the body - is one of the leading causes of death in the ICU.

8 Jan 2024

IU researchers aim to develop a new therapy for glaucoma

Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma, a complex disease that eventually leads to blindness, thanks to a new five-year, $2 million R01 grant from the National Eye Institute.

8 Jan 2024

Combining immunotherapy and radiation to tackle aggressive triple-negative breast cancer

Cedars-Sinai Cancer investigators have analyzed the cells within triple-negative breast cancer tumors before and after radiation therapy with immunotherapy, identifying three patient groups with different responses to the treatment.

8 Jan 2024

E-cigarettes more effective for smoking cessation than conventional nicotine-replacement therapy

Nicotine e-cigarettes are more effective in helping people quit smoking than conventional nicotine-replacement therapy (NRT), according to the latest Cochrane review co-led by a University of Massachusetts Amherst public health and health policy researcher.

8 Jan 2024

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Atrial fibrillation (AF) is a major global health concern impacting millions and causing symptoms like palpitations, dyspnea, fatigue, dizziness, and chest discomfort.

8 Jan 2024

Growing tiny tumors in the lab for personalized lung cancer treatment

Lung cancer accounts for nearly 20% of annual cancer-related deaths worldwide. According to 2022 statistics from the Swiss Cancer League, nearly 5,000 new cases of lung cancer are reported in Switzerland each year.

8 Jan 2024

Therapy News and Research

Zika virus effective in eliminating neuroblastoma tumors in mice, study finds

New study sheds light on the biological properties of new COVID variant Pirola

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Children with neuroblastomas may benefit from new drug cocktail

Marking a vital milestone for Vertex and Charles River

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Rising malpractice premiums price small clinics out of gender-affirming care for minors

Infammasomes provide a therapeutic target against human diseases

Amino acid nanoparticles show promise for cancer treatment

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Photobiomodulation alleviates Aβ deposition and cognitive decline in mice with Alzheimer’s disease

New peptide library paves the way for targeting elusive cancer factor MYC

URI robot aims to accelerate motor skill restoration for stroke patients

Unraveling the brain-fat pathway that dictates aging in mice

Three cytokine pairs found to be responsible for the body's damaging response to sepsis

IU researchers aim to develop a new therapy for glaucoma

Combining immunotherapy and radiation to tackle aggressive triple-negative breast cancer

E-cigarettes more effective for smoking cessation than conventional nicotine-replacement therapy

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Growing tiny tumors in the lab for personalized lung cancer treatment

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News